Latest Camber Capital Management LP Stock Portfolio
Camber Capital Management LP Performance:
2024 Q3: 5.3%YTD: 8.61%2023: 7.64%
Performance for 2024 Q3 is 5.3%, and YTD is 8.61%, and 2023 is 7.64%.
About Camber Capital Management LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Camber Capital Management LP reported an equity portfolio of $3.1 Billions as of 30 Sep, 2024.
The top stock holdings of Camber Capital Management LP are ZBH, MDT, BAX. The fund has invested 8.6% of it's portfolio in ZIMMER BIOMET HOLDINGS INC and 7.9% of portfolio in MEDTRONIC PLC.
The fund managers got completely rid off BIOMARIN PHARMACEUTICAL INC (BMRN), WALGREENS BOOTS ALLIANCE INC (WBA) and PERRIGO CO PLC (PRGO) stocks. They significantly reduced their stock positions in UNIVERSAL HLTH SVCS INC (UHS), THE BEAUTY HEALTH COMPANY (SKIN) and HUMANA INC (HUM). Camber Capital Management LP opened new stock positions in ASCENDIS PHARMA A/S, MEDPACE HLDGS INC (MEDP) and ALKERMES PLC (ALKS). The fund showed a lot of confidence in some stocks as they added substantially to SAREPTA THERAPEUTICS INC (SRPT), EVOLENT HEALTH INC (EVH) and ZIMMER BIOMET HOLDINGS INC (ZBH).
The top stock holdings of Camber Capital Management LP are ZBH, MDT, BAX. The fund has invested 8.6% of it's portfolio in ZIMMER BIOMET HOLDINGS INC and 7.9% of portfolio in MEDTRONIC PLC.
The fund managers got completely rid off BIOMARIN PHARMACEUTICAL INC (BMRN), WALGREENS BOOTS ALLIANCE INC (WBA) and PERRIGO CO PLC (PRGO) stocks. They significantly reduced their stock positions in UNIVERSAL HLTH SVCS INC (UHS), THE BEAUTY HEALTH COMPANY (SKIN) and HUMANA INC (HUM). Camber Capital Management LP opened new stock positions in ASCENDIS PHARMA A/S, MEDPACE HLDGS INC (MEDP) and ALKERMES PLC (ALKS). The fund showed a lot of confidence in some stocks as they added substantially to SAREPTA THERAPEUTICS INC (SRPT), EVOLENT HEALTH INC (EVH) and ZIMMER BIOMET HOLDINGS INC (ZBH).
Camber Capital Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Camber Capital Management LP made a return of 5.3% in the last quarter. In trailing 12 months, it's portfolio return was 19.16%.
New Buys
| Ticker | $ Bought |
|---|---|
| ascendis pharma a/s | 104,517,000 |
| concentra group holdings par | 44,161,000 |
| medpace hldgs inc | 41,725,000 |
| alkermes plc | 5,598,000 |
New stocks bought by Camber Capital Management LP
Additions
| Ticker | % Inc. |
|---|---|
| sarepta therapeutics inc | 416 |
| evolent health inc | 124 |
| zimmer biomet holdings inc | 29.87 |
| moonlake immunotherapeutics | 24.23 |
| medtronic plc | 22.22 |
| baxter intl inc | 18.18 |
| gsk plc | 12.15 |
Additions to existing portfolio by Camber Capital Management LP
Reductions
| Ticker | % Reduced |
|---|---|
| universal hlth svcs inc | -86.84 |
| the beauty health company | -57.14 |
| humana inc | -50.00 |
| myriad genetics inc | -28.18 |
| select med hldgs corp | -16.67 |
| zimvie inc | -16.15 |
| globus med inc | -14.00 |
| brookdale sr living inc | -10.1 |
Camber Capital Management LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| walgreens boots alliance inc | -84,665,000 |
| perrigo co plc | -39,034,000 |
| replimune group inc | -12,150,000 |
| biomarin pharmaceutical inc | -90,563,000 |
| curevac n v | -1,870,000 |
| anaptysbio inc | -12,530,000 |
| argenx se | -30,963,000 |
Camber Capital Management LP got rid off the above stocks
Sector Distribution
Camber Capital Management LP has about 85.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 85.8 |
| Others | 13.2 |
Market Cap. Distribution
Camber Capital Management LP has about 49.1% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 49.1 |
| MID-CAP | 28 |
| UNALLOCATED | 13.2 |
| SMALL-CAP | 8.9 |
Stocks belong to which Index?
About 68.8% of the stocks held by Camber Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 43.7 |
| Others | 31.2 |
| RUSSELL 2000 | 25.1 |
Camber Capital Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Camber Capital Management LP
Camber Capital Management LP has 32 stocks in it's portfolio. About 53.5% of the portfolio is in top 10 stocks. HUM proved to be the most loss making stock for the portfolio. UHS was the most profitable stock for Camber Capital Management LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALKS | alkermes plc | 0.18 | 200,000 | 5,598,000 | new | |||
| ANAB | anaptysbio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BAX | baxter intl inc | 7.84 | 6,500,000 | 246,805,000 | added | 18.18 | ||
| BCYC | bicycle therapeutics plc | 0.66 | 915,000 | 20,706,000 | unchanged | 0.00 | ||
| BKD | brookdale sr living inc | 3.00 | 13,935,000 | 94,619,000 | reduced | -10.1 | ||
| BKD | brookdale sr living inc | 0.73 | 250,000 | 23,089,000 | unchanged | 0.00 | ||
| BMRN | biomarin pharmaceutical inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CVAC | curevac n v | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CVS | cvs health corp | 3.00 | 1,500,000 | 94,320,000 | unchanged | 0.00 | ||
| DNLI | denali therapeutics inc | 1.85 | 2,000,000 | 58,260,000 | unchanged | 0.00 | ||
| EVH | evolent health inc | 1.26 | 1,400,000 | 39,592,000 | added | 124 | ||
| GMED | globus med inc | 4.88 | 2,150,000 | 153,811,000 | reduced | -14.00 | ||
| HLF | herbalife ltd | 0.69 | 3,000,000 | 21,570,000 | unchanged | 0.00 | ||
| HUM | humana inc | 2.01 | 200,000 | 63,348,000 | reduced | -50.00 | ||
| INGN | inogen inc | 0.62 | 2,000,000 | 19,400,000 | unchanged | 0.00 | ||
| JAZZ | jazz pharmaceuticals plc | 4.07 | 1,150,000 | 128,122,000 | unchanged | 0.00 | ||
| MDT | medtronic plc | 7.86 | 2,750,000 | 247,583,000 | added | 22.22 | ||
| MEDP | medpace hldgs inc | 1.32 | 125,000 | 41,725,000 | new | |||
| MLTX | moonlake immunotherapeutics | 0.71 | 441,000 | 22,235,000 | added | 24.23 | ||
| MYGN | myriad genetics inc | 3.44 | 3,950,000 | 108,191,000 | reduced | -28.18 | ||